GTR 108609800
Tenders Are Invited For Antineoplastic Agents – Supply Of 73 Types Of Oncological Drugs In The National Oncology Program And National Oncology Program Cost Volume.
ICB — International Competitive Bid
Closed
Eastern Europe
Tender Information
GTR Reference
108609800
Tendering Authority
Subscribe to view
Tender No
87066-2026
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Antineoplastic Agents – Supply Of 73 Types Of Oncological Drugs In The National Oncology Program And National Oncology Program Cost Volume.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Eastern Europe
Political Region
Balkans,European Union
Last Date of Bid Submission
11-03-2026
Closed
Work Detail
Antineoplastic Agents – Supply Of 73 Types Of Oncological Drugs In The National Oncology Program And National Oncology Program Cost Volume.. Zoledronic Acid 4Mg/5Ml,Afliberceptum - 25Mg/Mlx 4Ml,Afliberceptum - 25Mg/Ml X 8Ml,Atezolizumab - 1200Mg/20Ml,Atezolizumab - 1875Mg/15Ml,Avelumabum - 20Mg/Ml,Bevacizumabum - 25Mg/Ml X 4Ml,Bevacizumabum - 25Mg/Mg X 16Ml,Bleomycinum Sulfas - 15000Ui,Cabazitaxelum - 60 Mg/Ml,Calcii Folinas - 10Mg/Mlx10ml,Calcii Folinas - 10Mg/Ml X 35Ml,Carboplatinum - 10Mg/Ml X 15Ml,Carboplatinum - 10Mg/Ml X 45Ml,Carboplatinum - 10Mg/Ml X 60Ml,Cemiplimabum - 50Mg/Ml,Cetuximabum - 5Mg/Ml,Cisplatinum - 50 Mg,Cisplatinum - 10 Mg,Cyclophosphamidum - 200Mg,Cyclophosphamidum - 1000Mg/2Ml,Cyclophosphamidum - 500Mg/Ml,Dacarbazinum - 200Mg/Ml,Docetaxelum - 20Mg/Ml,Docetaxelum - 80Mg/4Ml,Doxorubicinum Lipozomala - 2Mg/Mlx10ml,Doxorubicinum Lipozomala - 2Mg/Mlx25ml,Doxorubicinum - 2Mg/Mlx25ml,Durvalumabum - 50Mg/Ml,Epirubicinum - 2Mg/Ml X25ml,Epirubicinum - 2Mg/Mi X 50 Ml,Eribulinum - 0,44 Mg/Ml,Etoposidum - 20Mg/Ml X 10Ml,Etoposidum - 20Mg/Ml X 5 Ml,Filgrastimum (G-Csf) - 30Mu/0,5 Ml,Fluorouracilum - 50Mg/Mlx20ml,Fluorouracilum - 50Mg/Mlx100ml,Gemcitabinum - 100Mg/Ml,Ifosfamidum - 1G,Ipilimumabum - 5Mg/Mlx10ml,Ipilimumabum - 5Mg/Mlx40ml,Irinotecanum - 20Mg/Ml X 10Ml,Irinotecanum - 20Mg/Ml X 15Ml,Mesnum - 400Mg/4Ml,Methotrexatum - 100Mg/Ml X 5 Ml,Nivolumabum - 10 Mg/Ml X4 Ml,Nivolumabum - 10 Mg/Ml X10 Ml,Nivolumabum - 10Mg/Ml X12ml,Oxaliplatinum - 5Mg/Mlx10ml,Oxaliplatinum - 5Mg/Mlx20ml,Paclitaxelum - 150 Mg,Paclitaxelum - 100 Mg,Paclitaxelum - 300 Mg,Naveruclif/ Naveruclif - 5Mg/Ml,Panitumumabum - 20Mg/Ml X 5Ml,Panitumumabum - 20Mg/Ml X 20Ml,Pembrolizumabum - 25 Mg/Ml X 4Ml,Pemetrexedum - 500Mg/Ml,Pertuzumabum - 420Mg/Ml,Ramucirumabum - 10 Mg/Ml,Sacituzumab Govitecan - 200Mg,Topotecamum - 1Mg/Ml,Trabectedinum - 1Mg/Ml,Trastuzumabum - 150Mg/Ml,Trastuzumabum Deruxtecanum - 100Mg/Ml,Trastuzumabum Emtansinum - 100Mg/Ml,Trastuzumabum Emtansinum - 160Mg/Ml,Vaccine Bcg - 100Mg/Ml,Doxorubicinum - 10 Mg/Ml,Doxorubicinum - 50 Mg/Ml,Vincristinum - 1Mg/Ml,Vinorelbinum - 10Mg/Ml,Vinorelbinum - 10Mg/Ml X 5Ml
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
aff9a655-6042-4228-a65a-2e8deb538de8.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.